Division of Pulmonary, Allergy, and Critical Care Medicine, Department of Medicine, School of Medicine, Pittsburgh, PA.
Department of Critical Care Medicine, CRISMA Center, School of Medicine, University of Pittsburgh, Pittsburgh, PA.
Med Care. 2024 Jun 1;62(6):388-395. doi: 10.1097/MLR.0000000000001997. Epub 2024 Apr 12.
Interrupted time series analysis of a retrospective, electronic health record cohort.
To determine the association between the implementation of Medicare's sepsis reporting measure (SEP-1) and sepsis diagnosis rates as assessed in clinical documentation.
The role of health policy in the effort to improve sepsis diagnosis remains unclear.
Adult patients hospitalized with suspected infection and organ dysfunction within 6 hours of presentation to the emergency department, admitted to one of 11 hospitals in a multi-hospital health system from January 2013 to December 2017. Clinician-diagnosed sepsis, as reflected by the inclusion of the terms "sepsis" or "septic" in the text of clinical notes in the first two calendar days following presentation.
Among 44,074 adult patients with sepsis admitted to 11 hospitals over 5 years, the proportion with sepsis documentation was 32.2% just before the implementation of SEP-1 in the third quarter of 2015 and increased to 37.3% by the fourth quarter of 2017. Of the 9 post-SEP-1 quarters, 8 had odds ratios for a sepsis diagnosis >1 (overall range: 0.98-1.26; P value for a joint test of statistical significance = 0.005). The effects were clinically modest, with a maximum effect of an absolute increase of 4.2% (95% CI: 0.9-7.8) at the end of the study period. The effect was greater in patients who did not require vasopressors compared with patients who required vasopressors ( P value for test of interaction = 0.02).
SEP-1 implementation was associated with modest increases in sepsis diagnosis rates, primarily among patients who did not require vasoactive medications.
回顾性电子健康记录队列的中断时间序列分析。
确定医疗保险脓毒症报告措施(SEP-1)的实施与临床文档中评估的脓毒症诊断率之间的关联。
卫生政策在改善脓毒症诊断方面的作用仍不清楚。
2013 年 1 月至 2017 年 12 月,在一家多医院卫生系统的 11 家医院之一就诊的,有疑似感染和器官功能障碍的成年患者,在就诊后 6 小时内入院。临床医生诊断的脓毒症,反映在就诊后前两个日历日内临床记录中的文本中包含“脓毒症”或“败血症”等术语。
在 5 年内,11 家医院共收治 44074 例成年脓毒症患者,在 2015 年第三季度实施 SEP-1 前,有脓毒症记录的患者比例为 32.2%,到 2017 年第四季度增加到 37.3%。在 9 个 SEP-1 后季度中,有 8 个季度的脓毒症诊断比值比大于 1(总体范围:0.98-1.26;P 值为联合检验统计学意义=0.005)。影响幅度较小,在研究期末,绝对增加 4.2%(95%CI:0.9-7.8)的效果最大。与需要血管加压药的患者相比,不需要血管加压药的患者的效果更大(P 值为交互检验=0.02)。
SEP-1 的实施与脓毒症诊断率的适度增加有关,主要是在不需要血管活性药物的患者中。